Publication | Open Access
Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease
11
Citations
9
References
2019
Year
Microbial PathogensImmunodeficienciesImmunologyPathologyVariable SusceptibilityMycobacterial DiseasesInnate ImmunityImmune SystemImmune-related Gene PolymorphismDisease SusceptibilityMycobacterial DiseaseMendelian DisorderHost GeneticsHost-pathogen InteractionsPrimary ImmunodeficiencyAutoimmune DiseaseMendelian SusceptibilityTuberculosisAutoimmunityClinical MicrobiologyInborn Error Of ImmunityMolecular MedicineMolecular Diagnostic TechniquesPathogenesisComplex DiseaseMedicineViral ImmunityChinese Patients
Mendelian Susceptibility to Mycobacterial Diseases (MSMD) is a primary immunodeficiency disease (PID) characterized by variable susceptibility to weakly virulent mycobacteria (Bacille Calmette-Guerin, BCG) and various intramacrophagic bacteria, fungi, parasites. Mycobacterial disease generally begins in childhood, more rarely during adolescence and adulthood. The pathogenesis of MSMD is the inherited impaired production of interferon gamma (IFN-γ) or inadequate response to it. Autosomal recessive IL12RB1 deficiency is the most common genetic etiology of MSMD. Here we identified three novel compound heterozygous mutations in IL12RB1 gene (c.635G>A, c.765delG; c.632G>C, c.847C>T; c.64G>A, c.1673insGAGCTTCCTGAG) in three Chinese families with MSMD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1